Visit the below You Tube link to see this month's message and previous messages.
https://www.youtube.com/watch?v=6tL5EqPoPGI&index=1&list=PLIa1oelW_zJ-ah4F-3P_hL8G_mdIzSD4q
Professor Hywel Williams the Director of the NIHR HTA Programme writes a monthly Director’s Message. This month’s message includes Hywel’s tips on how to improve your research application by getting a review from outside of your team, and Hywel’s appreciation of NIHR.
Visit the below You Tube link to see this month's message and previous messages.
https://www.youtube.com/watch?v=6tL5EqPoPGI&index=1&list=PLIa1oelW_zJ-ah4F-3P_hL8G_mdIzSD4q
5 January 2021
The WHiTE Four trial has now published its results in The Bone & Joint journal.
18 December 2020
The FUTURE GB Trial has received OCTRU Green Light approval and is now open to recruitment!
7 December 2020
The ARCADIAN trial has received OCTRU Green Light approval and has now begun to open sites to recruitment!
10 November 2020
Researchers in Oxford are looking to recruit women who have painful osteoarthritis in joints of their hands, after resuming a study that was paused due to the COVID crisis.
29 October 2020
The HUSH trial has received OCTRU Green Light approval and is now open to recruitment!
30 September 2020
Researchers at the University of Oxford are starting a new study to explore the effectiveness of the anti-tumour necrosis factor (anti-TNF) drug adalimumab as a treatment for patients with COVID-19 in the community, especially care homes. The AVID-CC trial, which will be conducted by Oxford Clinical Trials Research Unit (OCTRU), will enrol up to 750 patients from community care settings throughout the UK.